Market Value1,148,462,000
Total Holdings37
File Date2020-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NXTC / NextCure, Inc.
YMTX / Yumanity Therapeutics Inc
IOVA / Iovance Biotherapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc. Call
OPK / OPKO Health, Inc.
BOLD / Boundless Bio, Inc.
GWP / GW Pharmaceuticals plc
XLRN / Acceleron Pharma Inc
AXNX / Axonics, Inc.
LQDA / Liquidia Corporation
VRAY / ViewRay Inc.
ALLK / Allakos Inc.
MDCO / Medicines Company Call
PEN / Penumbra, Inc.
SILK / Silk Road Medical, Inc
TPTX / Turning Point Therapeutics Inc
MYOV / Myovant Sciences Ltd
STRM / Streamline Health Solutions, Inc.
ZGNX / Zogenix Inc Call
TNDM / Tandem Diabetes Care, Inc.
ABEO / Abeona Therapeutics Inc.
NKTR / Nektar Therapeutics
ZGNX / Zogenix Inc
MTEM / Molecular Templates, Inc.
CYTK / Cytokinetics, Incorporated
TGTX / TG Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc. Call
US60877T1007 / Momenta Pharmaceuticals, Inc.
AUPH / Aurinia Pharmaceuticals Inc. Call
DXCM / DexCom, Inc.
VYNE / VYNE Therapeutics Inc.
DERM / Journey Medical Corporation
TCDA / Tricida Inc
ZYME / Zymeworks Inc.
ACAD / ACADIA Pharmaceuticals Inc.
UTHR / United Therapeutics Corporation
ATRA / Atara Biotherapeutics, Inc.
KURA / Kura Oncology, Inc.
US2103731061 / Constellation Pharmaceuticals Inc
BBIO / BridgeBio Pharma, Inc.
TPST / Tempest Therapeutics, Inc.
GNFT / Genfit S.A.
EXEL / Exelixis, Inc.
PRTA / Prothena Corporation plc
PTCT / PTC Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc. Put
MRTX / Mirati Therapeutics, Inc. Call
SAGE / Sage Therapeutics, Inc.
INSM / Insmed Incorporated
IONS / Ionis Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Call
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ARVN / Arvinas, Inc.
OPTN / OptiNose, Inc.